UnitedHealth Group Incorporated (UNH · NYSE)

UNH · MARKET VIEW

Market view · as of Sep 14, 2026

Revenue (TTM)
$450.53B
+0.4% YoY
Gross margin
19.7%
EPS (latest q)
$6.38
vs $4.94 est · beat
52-wk position
68.0%
-13.1% vs 52w high · -5.0% 1mo

Price (last ~year)

UnitedHealth Group (UNH) posted a 61.5% year-over-year increase in earnings despite TTM revenue growth of 0.4% on $450.53B in total revenue. The company has surpassed earnings estimates for four consecutive quarters, reporting $5.48B in net income for the period ending June 30, 2026. Shares are currently priced at $379.09, down 7.0% over the last three months with a P/E ratio of 24.39.

Valuation

Market cap
$340.27B
P/E
24.39
PEG
1.03
P/B
3.456
P/S
0.755
EV/EBITDA
14.92
Beta
0.622
Analyst target
$475.23

Quality & returns

Gross margin
19.7%
Operating margin
7.1%
Profit margin
3.1%
ROE
14.1%
ROA
4.9%

Price movement

Last
$379.09
1-month
-5.0%
3-month
-7.0%
RSI (14)
42
vs SMA200
+8.1%
52-wk position
68.0% -13.1% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$112.03B$7.99B$5.48B$8.97B
2026-03-31$111.72B$8.99B$6.28B$10.09B
2025-12-31$113.22B$380.0M$10.0M$1.37B
2025-09-30$113.16B$4.32B$2.35B$5.33B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots